Tuesday - December 24, 2024

Liquid Biopsy to Detect Cancer Early and Sensitively in Patients With Neurofibromatosis Type 1

2024-11-12

ALEXANDRIA, Virginia, Nov. 12 -- NATIONAL INSTITUTES OF HEALTH, Bethesda, Maryland has been assigned a patent (No. US 12140595 B2, initially filed Jan. 27, 2022) developed by six inventors Aadel Chaudhuri, St. Louis, Missouri; Paul Jones, St. Louis, Missouri; Jeffrey Szymanski, St. Louis, Missouri; Angela Hirbe, St. Louis, Missouri; Russell Sundby, Baltimore, Maryland; and John Shern, Bethesda, Maryland, for "Liquid biopsy to detect cancer early and sensitively in patients with neurofibromatosi . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Liquid Biopsy to Detect Cancer Early and Sensitively in Patients With Neurofibromatosis Type 1

Information Request Form

Copyright Targeted News Service 2024